Abstract
With over 10 million new cases per year worldwide, Cancer remains one of the most urgent health concerns and a difficult disease to treat. For an effective treatment, improved diagnostic and therapeutic techniques with minimal side-effects are required. Research and development in the areas of nanoscience and nanotechnology promise to provide innovative and more effective approaches for early diagnosis, imaging and therapy. An emerging trend in this direction is Theranostics which represents a combinatorial diagnosis and therapeutic approach to cancer disease and aims to eliminate multi-step procedures, reduce delays in treatment and improves patient care. It offers various advantages like improved diagnosis, tumor specific delivery of drugs, reduced lethal effects to normal tissues etc. Theranostic nanomedicines like nanoshells, plasmonic nanobubbles, quantum dots etc. can be used effectively for achieving these goals. With the advances in nano-imaging and nano-therapy new avenues for the development of effective cancer treatment will be opened.
Keywords: Diagnosis, cancer, nanomedicines, theranostics.
Current Drug Delivery
Title:Theranostics for Cancer Therapy
Volume: 10 Issue: 3
Author(s): Pradnya Palekar- Shanbhag, Sneha V. Jog, Manasi M. Chogale and Sujata S. Gaikwad
Affiliation:
Keywords: Diagnosis, cancer, nanomedicines, theranostics.
Abstract: With over 10 million new cases per year worldwide, Cancer remains one of the most urgent health concerns and a difficult disease to treat. For an effective treatment, improved diagnostic and therapeutic techniques with minimal side-effects are required. Research and development in the areas of nanoscience and nanotechnology promise to provide innovative and more effective approaches for early diagnosis, imaging and therapy. An emerging trend in this direction is Theranostics which represents a combinatorial diagnosis and therapeutic approach to cancer disease and aims to eliminate multi-step procedures, reduce delays in treatment and improves patient care. It offers various advantages like improved diagnosis, tumor specific delivery of drugs, reduced lethal effects to normal tissues etc. Theranostic nanomedicines like nanoshells, plasmonic nanobubbles, quantum dots etc. can be used effectively for achieving these goals. With the advances in nano-imaging and nano-therapy new avenues for the development of effective cancer treatment will be opened.
Export Options
About this article
Cite this article as:
Shanbhag Pradnya Palekar-, Jog Sneha V., Chogale Manasi M. and Gaikwad Sujata S., Theranostics for Cancer Therapy, Current Drug Delivery 2013; 10 (3) . https://dx.doi.org/10.2174/1567201811310030013
DOI https://dx.doi.org/10.2174/1567201811310030013 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
First Total Synthesis of ω-Phenyl Δ6 Fatty Acids and their Leishmanicidal and Anticancer Properties
Current Topics in Medicinal Chemistry The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma
Current Cancer Drug Targets Nanoparticles: A Neurotoxicological Perspective
CNS & Neurological Disorders - Drug Targets The-N-End Rule: The Beginning Determines the End
Protein & Peptide Letters Synthesis of Pyrrole-Based Macrocycles as Molecular Probes for Multimodal Imaging Techniques: Recent Trends
Current Organic Synthesis The Potency of Refined Mouse Models: Implications for Clinical Trials
Current Cancer Therapy Reviews Isolation of Secreted microRNAs (miRNAs) from Cell-conditioned Media
MicroRNA Autoantibodies in Autoimmune Diseases
Current Pharmaceutical Design The Relationship between Pharmacological Properties and Structure- Activity of Chrysin Derivatives
Mini-Reviews in Medicinal Chemistry Biologics: An Update and Challenge of Their Pharmacokinetics
Current Drug Metabolism Human Microdialysis
Current Pharmaceutical Biotechnology Randomized Controlled Clinical Trials in Mild-Moderate Ulcerative Colitis
Reviews on Recent Clinical Trials Vascular Effects of Phytoestrogens and Alternative Menopausal Hormone Therapy in Cardiovascular Disease
Mini-Reviews in Medicinal Chemistry Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
Current Medicinal Chemistry Structural Insights for Drugs Developed for Phospholipase D Enzymes
Current Drug Discovery Technologies Prediction of MicroRNA–disease Associations by Matrix Completion
Current Proteomics Coagulation and Cancer Therapy: The Potential of Natural Compounds
Current Genomics Editorial (Thematic Issue: The Predictive Pathology in the Target Therapy Era)
Current Drug Targets Pharmacogenomics of Arylamine N-acetyltransferase
Current Pharmacogenomics Key Role of Mitochondria in Alzheimer’s Disease Synaptic Dysfunction
Current Pharmaceutical Design